SG Americas Securities’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-172,525
| Closed | -$16.7M | – | 3532 |
|
|
2019
Q3 | $16.7M | Buy |
172,525
+167,256
| +3,174% | +$16.7M | 0.14% | 129 |
|
|
2019
Q2 | $539K | Sell |
5,269
-311,791
| -98% | -$33.6M | ﹤0.01% | 1843 |
|
|
2019
Q1 | $36.1M | Buy |
317,060
+312,254
| +6,497% | +$23M | 0.33% | 48 |
|
|
2018
Q4 | $188K | Buy |
4,806
+313
| +7% | +$13.6K | ﹤0.01% | 2424 |
|
|
2018
Q3 | $245K | Buy |
4,493
+2,246
| +100% | +$154K | ﹤0.01% | 2466 |
|
|
2018
Q2 | $186K | Sell |
2,247
-5
| -0.2% | -$386 | ﹤0.01% | 2645 |
|
|
2018
Q1 | $150K | Sell |
2,252
-30,354
| -93% | -$1.75M | ﹤0.01% | 2643 |
|
|
2017
Q4 | $1.68M | Buy |
32,606
+15,493
| +91% | +$1.11M | 0.02% | 1013 |
|
|
2017
Q3 | $1.53M | Buy |
17,113
+13,688
| +400% | +$1.04M | 0.01% | 965 |
|
|
2017
Q2 | $205K | Sell |
3,425
-831
| -20% | -$46.4K | ﹤0.01% | 2410 |
|
|
2017
Q1 | $227K | Sell |
4,256
-9,431
| -69% | -$560K | ﹤0.01% | 2355 |
|
|
2016
Q4 | $683K | Buy |
13,687
+10,560
| +338% | +$566K | 0.01% | 1516 |
|
|
2016
Q3 | $188K | Buy |
+3,127
| New | +$180K | ﹤0.01% | 2553 |
|
|
2016
Q2 | – | Sell |
-15,393
| Closed | -$454K | – | 3162 |
|
|
2016
Q1 | $454K | Buy |
+15,393
| New | +$486K | ﹤0.01% | 1797 |
|
SG Americas Securities's ONCE Position: Q4 2019 in Review
SG Americas Securities sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 172,525 shares — an estimated $16.7M sold.
SG Americas Securities first reported a position in ONCE in Q1 2016 and held it in 14 quarters. The position peaked at $36.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- SG Americas Securities reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- SG Americas Securities sold 172,525 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $16.7M.
- SG Americas Securities first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and held it in 14 quarters.
- SG Americas Securities's Spark Therapeutics, Inc. Common Stock position peaked at $36.1M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on SG Americas Securities's 13F filing for Q4 2019, filed 28 Jan 2020.